Quick filters
- Sanofi and Regeneron Announce Patient Enrollment in Two Phase 3 Trials with Sarilumab in Rheumatoid Arthritis (RA) PR Newswire | Wednesday May 15, 2013 1:00AM
- Regeneron Announces Upcoming 2013 Investor Conference Presentations PR Newswire | Wednesday May 8, 2013 9:30AM
- Regeneron raises 2013 Eylea sales view, profit beats Street Globe and Mail | Friday May 3, 2013 7:04AM
- Regeneron Acquires Full Rights to Two Novel Ophthalmology Development Programs PR Newswire | Friday May 3, 2013 6:30AM
- Regeneron Reports First Quarter 2013 Financial and Operating Results PR Newswire | Friday May 3, 2013 6:30AM
- UPDATE 3-Allergan delays drug that would rival Regeneron's Eylea Globe and Mail | Wednesday May 1, 2013 5:45PM
- REFILE-UPDATE 2-Allergan delays drug that would rival Regeneron's Eylea Globe and Mail | Wednesday May 1, 2013 3:33PM
- UPDATE 2-Allergan delays drug that would rival Regeneron's Eylea Globe and Mail | Wednesday May 1, 2013 2:52PM
- BRIEF-Allergan resumes trading down 11.5 percent after company says phase 2 eye drug data does not support directly moving to phase 3 Globe and Mail | Wednesday May 1, 2013 11:18AM
- BRIEF-Regeneron Pharma shares resume trading, up 16 percent Globe and Mail | Wednesday May 1, 2013 11:18AM
- BRIEF-Regeneron Pharma shares halted, last up 14.3 pct Globe and Mail | Wednesday May 1, 2013 11:13AM
- MARKET PULSE-Dow, Biogen, Harley-Davidson, Akamai, Zynga Globe and Mail | Thursday April 25, 2013 7:35AM
- Regeneron Set to Join the S&P 500; Eagle Materials, CST Brands to Join the S&P MidCap 400; Francesca's, Northern Oil & Gas to Join the S&P SmallCap 600 PR Newswire | Wednesday April 24, 2013 6:18PM
- BRIEF-Regeneron Pharma shares up 2.8 pct after the bell Globe and Mail | Wednesday April 24, 2013 5:46PM
- BRIEF-S&P 500 to add Regeneron, drop MetroPCS Globe and Mail | Wednesday April 24, 2013 5:36PM
- Regeneron Announces Upcoming 2013 Investor Conference Presentations PR Newswire | Thursday April 18, 2013 9:30AM
- Regeneron Pharmaceuticals Announces Expansion in New York's Hudson Valley PR Newswire | Thursday April 4, 2013 9:15AM
- BioMed Realty To Develop 297,000 Square Feet In New York Fully Leased To Regeneron Pharmaceuticals PR Newswire | Thursday April 4, 2013 9:15AM
- Regeneron Announces Potential Additional Royalty Stream Related to EU Approval for Ilaris® (canakinumab) in Patients Suffering Acute Gouty Arthritis Attacks Who Cannot Gain Relief From Current Treatments PR Newswire | Monday March 4, 2013 9:00AM
- Sanofi and Regeneron Report Positive Proof-of-Concept Data for Dupilumab, an IL-4R alpha Antibody, in Atopic Dermatitis PR Newswire | Saturday March 2, 2013 9:00AM
Live Discussion of REGN on StockTwits